Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Executive Vice President & CFO
-
Stock Symbol
-
AMRX on Nasdaq
Tasos Konidaris - trading volume in the past year for Amneal Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Class A Common Stock |
622K |
$5.54M |
$8.91 |
Mar 5, 2025 |
Direct |
|
|
Performance-Based Restricted Stock Units |
228K |
$2.02M |
$8.84 |
Mar 3, 2025 |
Direct |
Class A Common Stock |
|
Restricted Stock Units |
132K |
$1.17M |
$8.84 |
Mar 4, 2025 |
Direct |
Class A Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.